Bain Capital Life Sciences Opportunities III, LP 13D and 13G filings for Cabaletta Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-08-22 6:10 pm Purchase |
2024-08-12 | 13G | Cabaletta Bio, Inc. CABA |
Bain Capital Life Sciences Opportunities III, LP | 2,760,888 5.700% |
760,888![]() (+38.04%) |
Filing |
2024-02-13 6:47 pm Unchanged |
2023-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Bain Capital Life Sciences Opportunities III, LP | 2,000,000 4.700% |
0 (Unchanged) |
Filing |
2023-06-01 4:45 pm Purchase |
2023-05-22 | 13G | Cabaletta Bio, Inc. CABA |
Bain Capital Life Sciences Opportunities III, LP | 2,000,000 5.000% |
2,000,000![]() (New Position) |
Filing |